 |
When applied directly to an actively bleeding wound, each Arista™AH particle acts as a molecular sieve to instantly extract fluids from blood. |
 |
 |
This powerful osmotic action causes the particle to swell and concentrates serum proteins, platelets and other formed elements on its surface. |
 |
 |
The particles and their coating of compacted cells create a scaffolding for the formation of a tenacious fibrin clot within just minutes of application. |
 |
 |
The Arista™AH particles are fully absorbed and enzymatically cleared from the wound site within 24 to 48 hours. |
 |
of adverse events.
Arista™AH is indicated in surgical procedures (except neurological and ophthalmic) as an adjunctive hemostatic device to assist when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical.
See Administration section of Instructions for Use (PDF) document.
